A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor by unknown
A 275 BASEPAIR FRAGMENT AT THE 5' END OF THE
INTERLEUKIN 2 GENE ENHANCES EXPRESSION FROM A
HETEROLOGOUS PROMOTER IN RESPONSE TO SIGNALS
FROM THE T CELL ANTIGEN RECEPTOR
BY DAVID B. DURAND,* MARK R. BUSH,* JOHN G. MORGAN,*
ARTHUR WEISS,* AND GERALD R. CRABTREE*
From the *Department ofPathology, Stanford University Medical School,
Stanford, California 94305; and the *Department ofMedicine, Howard Hughes Medical
Institute, The University of California, San Francisco, California 94143
The process of T cell activation involves the interaction of antigen with the
antigen receptor (Ti)'/T3 complex (1-4), activation of protein kinase C (5-7),
andan increase in the intracellular concentration ofcalcium (8-11). These events
must specifically regulate a limited number of genes in the nucleus, which
program Tcell division and differentiated Tcell functions. Still, to date, little is
known about the signals that must pass between the antigen receptor and the
genes that are the targets ofthese signals. One approach to understanding these
intracellular signals in T lymphocyte activation involves first defining the precise
DNA targets for these signals and then using these DNA sequences to isolate the
signal molecules.
The interleukin 2 gene, one ofthe earliest genes tobeactivated by these signal
molecules, is expressed by T lymphocytes in a strictly regulated manner. Resting
T cells make no detectable IL-2 transcripts (12); however, the combination of
antigen in the presence of the appropriate antigen presenting cell leads to the
activation of the IL-2 gene (12, 13). This is a primary gene activation, because
no protein synthesis is required for IL-2 gene transcription (12). The kinetics of
induction are quite rapid, with transcripts detectable in total cellular RNA
preparations within 1 h (14, 15). Recently, we found that a nuclease hypersensi-
tive site is induced ^-85 by 5' to the initiation site of transcription of the IL-2
gene (16). The appearance of this site coincides with the onset of IL-2 gene
transcriptionin human peripheral blood T cells and the human T cell lineJurkat.
Furthermore, at least one agent known to block IL-2 gene activation, cyclosporin
A, inhibits the appearance of this site (16). We now demonstrate that the IL-2
5'-flanking region contains a 275 by sequence that, in either orientation, en-
hances transcription from a heterologous promoter. Moreover, this 275 by
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sequence is a target for the signal pathway originating at the T cell antigen
receptor .
Materials and Methods
PlasmidConstructs.
￿
The IL-2 CAT plasmid wasmade using the 632 by Rsa I fragment
of the 5' flanking region of the human IL-2 gene, which was lightly digested with BAL
31 to remove the initiator codon from its 3' end (16) . The 5' overhanging ends of the
resulting fragments were then filled in using Klenow enzyme, ligated to Hind III linkers,
and then ligated to the chloramphenicol acetyltransferase (CAT) gene from the T r,9
transposon after digestion with Hind III enzyme . There are no simian virus 40 sequences
in this plasmid except for the splice and polyadenylation sequences at the 3' end of the
CAT gene (16) . For these experiments we used an IL-2 CAT plasmid that has just 7 by
removed from each end relative to the original 632 by Rsa I fragment .
The y fibrinogen promoter construct was prepared by subcloning the 6.5 kb Xho I
fragment carrying the rat 7 fibrinogen upstream region and its first seven introns (17)
into the Sal I site of pBR322 . This plasmid was digested with Pvu 11 and Bst Ell ; the
resultant 822 by fragment was isolated and its termini were filled in using Klenow enzyme .
Following attachment of synthetic Hind III linkers, the fragment was ligated onto the
Hind III site ofpJYMCAT (16) . This plasmid consisting of -y fibrinogen sequences -792
to +36 linked to the CAT gene was linearized at the Cla I site in the polylinker containing
the 5' Hind III site, and a series of 5' deletions were constructed by Bal 31 digestion,
followed by filling in using Klenow enzyme and adding of synthetic Sph I linkers . One
such 5' deletion mutant is referred to as Fib CAT (containing nucleotides -54 to +36 of
the .y fibrinogen gene, as determined by sequencing [J . Morgan, E . Evans, L . A . Campbell,
and G . R . Crabtree unpublished data]) .
The IL-2 Fib CAT constructs were made by isolating the fragments indicated in Fig . 1
from IL-2 CAT ; filling in 5' overhangs, where necessary, using Klenow enzyme ; ligating
synthetic Sph I linkers to the blunt ends ; and ligating the resulting fragments in both
orientations into the Sph I site of Fib CAT . The constructs containing the IL-2 Xmn I to
Ssp I fragment in forward and reverse orientations are referred to as IL-1 Fib CAT and
1 1L2 Fib CAT, respectively . All enzymes were obtained from New England Biolabs
(Beverly, MA) . All cloning procedures were performed as previously described (16) .
Transfections.
￿
Jurkat cells were transfected by a modified DEAE-dextran method (16) .
The Jurkat mutant lacking T3/Ti complex surface expression was previously described
(2, 3) . Briefly, aliquots of 12 x 106 Jurkat cells grown in RPMI 1640 with 10% FCS and
1% penicillin/streptomycin (Difco Laboratories, Chagrin Falls, OH) (final medium) were
washed once in RPMI 1640 by centrifugation (all spins ofJurkat cells were at 200 g for 5
min) and were gently resuspended in 2 ml 250 ug/ml DEAE-dextran (mol wt 5 x 10 5 ;
Sigma Chemical Co ., St . Louis, MO), 0.1 mM chloroquine diphosphate (Sigma Chemical
Co .), and 10,ug/ml DNA in RPMI 1640 at 25 °C . The aliquots were incubated at room
temperature for 70 min, spun down, washed once in RPMI 1640, and then resuspended
in 15 ml final medium . The cells were stimulated with various reagents, as described in
Results, 8 h before harvest . Final concentrations used were PHA-P (Sigma Chemical Co .),
2,ug/ml ; PMA (Sigma Chemical Co .), 50 ng/ml ; C305 antibody, 1 :10,000 (2) ; anti-HLA,
1 :10,000 (W6/32) (5) ; and A23187 (Calbiochem Behring Corp ., La Jolla, CA), 1 jug/ml .
Cells were harvested 50-52 h after transfection, and the protein extracts were tested for
CAT activity as described (18) . The entire extract (0.4 mg protein) was incubated in the
presence of 2 .75 mM acetyl coenzyme A and 1 Al of [' 4C]chloramphenicol (Amersham
Corp ., Arlington Heights, IL) at 37°C for 18 h . Samples were subsequently run on thin-
layer chromatography plates as described (18), and the plates were exposed to x-ray film
for 24-48 h at -70°C with one intensifying screen . After autoradiography, the zones
containing converted and unconverted ['4C]chloramphenicol were cut out and scraped to
allow quantitation of the percent conversion to acetylated forms . Counting was performed
in Aquafluor (New England Nuclear, Boston, MA) .
IL-2 Assays .
￿
Assays were performed on the supernatants of the transfected Jurkat cells
as described (19) .DURAND ET AL .
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FIGURE 1 .
￿
The delimitation of IL-2 sequences that enhance expression from a heterologous
promoter in response to PHA plus PMA treatment. A mapof the IL-2 5' flanking region and
first exon is shown at the top of the figure . The inducible nuclease sensitive site (NSS), the
TATA box (TATAAA), and the location of the first ATG codon (Met) are indicated . The
region is numbered according to the start site of transcription (at 0) . The composition of the
transfected constructs is indicated at left . The construct described on the first line is IL-2
CAT, which contains the IL-2 5' flanking region (-576 to +42) ligated to the CAT gene . For
the other constructs shown, the given IL-2 sequences were ligated to the y fibrinogen
promoter, which in turn is ligated to the CAT gene . The arrows indicate the orientation o£
the IL-2 sequences relative to the y fibrinogen promoter. Jurkat cells were transfected with
the various constructs andwere stimulated 42 to 44 h later with PHA and PMA, or were left
unstimulated (as indicated by a plus or aminus, respectively, in the PHA + PMA column) . 8 h
later the CAT protein was extracted and the CAT activity of the extracts was determined .
The activity is expressed as ranges of percent ['4Clchloramphenicol conversion, as explained
in Results . Inducibility is definedby the criterion ofnonoverlapping ranges between stimulated
and unstimulated samples (see Results for further explanation) .
Results
Identification of a 275 by DNA Fragmentfrom the IL-2 5' Flanking Region that
Enhances Expression from a Heterologous Promoter in Transfected Jurkat Cells in
Response to PHA plus PMA Stimulation . To study the molecular signals that
activate the IL-2 gene, we have begun to define the shortest sequence from the
5' flanking region of the gene that is responsive to the signals that induce
endogenous IL-2 gene expression . We started our search for such sequences in
the 5' flanking region of the IL-2 gene for two reasons. First, this is the most
frequent location for regulatory sequences in differentiation-specific genes (20-
23) . More important, we have identified an inducible nuclease-sensitive site in
the immediate IL-2 5' flanking region that may represent a regulatory protein
binding site (16) . The appearance of this nuclease sensitive site (NSS in Fig . 1)
was inhibitable with cyclosporin A, a drug that inhibits the induced transcription
of the IL-2 gene (24), further indicating the potential importance of this region
in the regulation of the IL-2 gene (16) .
To identify regulatory sequences within the IL-2 5' flanking region, we initially
IL-2
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linked the IL-2 sequences extending from -576 to +42 to the CAT coding
region, and assayed the function of this plasmid, IL-2 CAT, in transiently
transfected Jurkat cells (16) . Fig . 1 shows schematically that the -576 to +42
sequence contains the inducible nuclease-sensitive site as well as a TATA box.
IL-2 CAT lacks the IL-2 ATG codon for the first methionine, such that the
CAT transcripts must initiate translation at the AUG of the CAT gene . Jurkat
cells were transfected and were then stimulated with PHA andPMA or were left
unstimulated (see Materials and Methods) . 8 h later, the protein was extracted
from the cells and assayed forCAT activity . This time was selected because the
peak of accumulated IL-2 transcripts occurs ^"6 h after stimulation with PHA
and PMA (the additional 2 h allow sufficient time forCAT translation to occur)
(24) . The acetyltransferase activity of the cellular extract has been shown to
reflect the level of accumulated CAT transcripts in a given transfected cell line
(25, 26) . Since IL-2 gene expression is controlled primarily at the transcriptional
level (12), acetyltransferase activity should reflect the transcriptional regulatory
activity of the IL-2 5' flanking sequences in a particular construct, provided the
transcriptional start site is not shifted such that an out-of-phase methionine is
used .
Fig. 1 indicates that when Jurkat cells were transfected with IL-2 CAT and
stimulated with PHA plus PMA (noted by a + in the PHA plus PMA column),
the range of percent ['4C]chloramphenicol conversion was 6.2-7.1%, while for
unstimulated transfected cells the range was 0.13-0.17% (ranges for three
experiments) . This and subsequent figures represent data pooled from multiple
complete experiments, including the specific controls indicated in each of the
figures. Data pertaining to a givenconstruct transfected underspecific conditions
could be pooled and expressed as ranges, because the time course of the
transfections, the time ofCAT protein extraction and the duration of the CAT
assay were kept constant in these experiments . Because the range of percent
conversion for cells that underwent the transfection process in the absence of
DNA (i.e ., mock-transfected cells) overlapped the range of percent conversion
for transfected unstimulated cells (0 .12-0.23 and 0.13-0.17, respectively), we
concluded that there was no detectable constitutive expression of the IL-2 CAT
construct in Jurkat cells . When the mock-transfected values are subtracted from
the values for DNA-transfected unstimulated cells, the difference approaches
zero and the induction of stimulated transfected cells relative to unstimulated
transfected cells approaches infinity . For this reason our results are expressed in
terms of inducibility (+ under Inducibility in Fig . 1) or noninducibility (- under
Inducibility in Fig . 1) . The conclusions indicated by the inducibility column in
Fig . 1 are based on the statistical test of nonoverlapping ranges . In other words,
where the PHA plus PMA-positive range is greater than and does not overlap
with the PHA plus PMA-negative range, the plasmid is considered inducible .
Where these ranges overlap, the given plasmid is considered noninducible .
Where experiments were performed once, single values are given . For IL-2
CAT, ourconclusion was that the plasmidwasconstitutively inactive, but strongly
inducible with PHA plus PMA.
To further delineate the inducing sequences, we have begun to define the
shortest fragment from the IL-2 5' flanking region that will enhance transcription
from an unrelated promoter . The heterologous promoter we chose isa truncatedDURAND ET AL.
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y fibrinogen promoter including only 22 by 5' to the TATA box linked to the
CAT gene by 36 by of 5' untranslated region . This FibCAT construct functions
at a low constitutive level in hepatocytes, which is at least 40 times lower than
the activity of longer 5' deletion mutants . In addition, FibCAT correctly initiates
transcription in vivo (Morgan et al ., unpublished observations) and nuclear run-
off experiments indicate that the control of y fibrinogen expression is at the
transcriptional level (Zlotnick, A., andG. Crabtree, unpublished observations) .
To identify a minimal control sequence, various fragments from the original 618
by IL-2 5' flanking region (shown schematically as arrows in Fig . 1) were ligated
to Fib CAT at the 5' end of the fibrinogen sequences in both orientations with
respect to the y fibrinogen promoter (i.e ., IL-2 sequence, y fibrinogen promoter ;
CAT coding sequence) . These plasmids were transfected into Jurkat cells that
were then stimulated with 'PHA and PMA, or were left unstimulated . As
illustrated in lines 2 and 3 of Fig . 1, only the IL-2 -326 to -52 fragment (Xmn
I to SspI ; in both forward and reverse orientations, IL-
￿
Fib CAT and tL- -2 Fib
CAT, respectively) could enhance expression from the fibrinogen promoter in
response to PHA plus PMA treatment . The -326 to -164 (Xmn I to Dra 1), the
-164 to -52 (Dra I to Ssp I), and the -230 to -52 (Dde I to Ssp 1) fragments
were unable to enhance expression from the fibrinogen promoter in stimulated
cells (Fig. 1) . It should be noted that no constitutive expression of these plasmids
could be detected above the low endogenous acetyltransferase activity ofJurkat
cells. In short, the 275 by Xmn I to Ssp I fragment represents the shortest IL-2
5' flanking sequence examined that could enhance expression from a heterolo-
gous promoter in response to PHA plus PMA treatment . The shorter fragments
could be interpreted as transcriptionally inactive due toashift in the transcription
initiation sites, so that strictly speaking, this 275 by fragment represents the
shortest fragment that enhances transcription in such a way as to produce a CAT
mRNA that can be properly translated . As mentioned, however, both IL-2 and
y fibrinogen expression are controlled at the transcriptional level . Furthermore,
Fib CAT initiates transcription correctly in vivo (Morgan et al ., unpublished
data), and CAT activity has reflected the .level of accumulated CAT transcripts
in several previously examined systems (25, 26) . Finally, as discussed below, this
275 by IL-2 fragment responds to various activation stimuli in parallel to
expression of the endogenous IL-2 gene . For these reasons, it is likely that our
results reflect changes at the level of transcript accumulation rather than differ-
ences in initiation start sites .
The IL-2 5' Flanking Region Confers Inducibility upon an Unrelated Promoter
after Stimulation of TransfectedJurkat Cells with Anti-Ti plus PMA . PHA binds to
multiple cell surface molecules on T lymphocytes, but may initiate activation by
triggering the T3/Ti complex (2, 8) . To ascertain that the IL-2 5' flanking
region was receiving the physiologic signal from a pathway beginning at the
antigen receptor, we used the antibody C305, which binds to the ,Q chain of the
antigen receptor component of the T3/Ti complex at theJurkat cell membrane
(2, 3, and A. Weiss, unpublished observations) . Weiss and coworkershave shown
that this antibody induces IL-2 protein expression in the presence ofPMA (2) .
Furthermore, when presented singly to Jurkat cells, neither C305, PMA, nor
PHA yields a substantial response (2). OnlyPHA induces detectable secreted IL-400 INTERLEUKIN 2 GENE TARGET FOR ANTIGEN RECEPTOR SIGNALS
TABLE I
Response ofthe Transfected IL-2 CATPlasmid in thejurkat T Cell
Line to Membrane and/or Cytosolic Signals
jurkat cells were transfected with the IL-2 CAT plasmid and were
subsequently treated with the stimuli noted in the far left column . CAT
protein was extracted 8 h later and CAT assays were performed as
described (see Materials and Methods) . The CAT assay results, given as
percent conversion (range), represent three to eight separate experi-
ments, except where single values are given . These values were normal-
ized to a mean CAT assay time of 18.2 h on the assumption that the
CAT assay is linear with respect to time (18 and our unpublished
observations) . CAT assay times varied in these experiments from 16.2
to 22.3 h . Inducibility is defined by the criterion of nonoverlapping
ranges between stimulated and unstimulated samples. IL-2 production
is given in the far right column in units per milliliter.
* None refers to jurkat cells that underwent transfection with DNA but
were not stimulated .
$ Mock refers to jurkat cells that underwent the transfection process in
the absence ofDNA and without stimulation .
2 activity, and this represents -'/14th of thePHA plus PMA-induced activity (8) .
The ability of PHA alone to induce small amounts of IL-2 may reflect its
interaction with cell surface molecules other than the T3/Ti complex . To
examine signal specificity we transfectedjurkat cells with IL-2 CAT and stimu-
lated the cells for 8 h with the stimuli indicated in the first column of Table I .
IL-2 production, a measure ofendogenous IL-2 gene expression, was monitored
by assaying the supernatants at the time of cell harvest, and is expressed in units
per milliliter in the fourth column . Table I shows that the range of percent
conversions for the stimulus combination anti-Ti plus PMA (0.62-2.0) was
greater than and did not overlap with the range of percent conversions for
unstimulated transfected cells (0.13-0.23), for anti-Ti alone (0 .16-0.40), or for
PMA alone (0 .18-0.35) in three separate experiments ; hence, the combination
of anti-Ti and PMA was capable of activating expression of IL-2 CAT, while
anti-Ti alone and PMA alone were not . As a control for the specificity of the
anti-Ti antibody, we used an antibody that recognizes an HLA antigen on the
jurkat cell membrane (6) . Neither anti-HLA plus PMA nor anti-HLA alone
induced IL-2 CAT expression in Jurkat . In nearly every experiment, the expres-
sion of the introduced plasmids paralleled the expression of the endogenous IL-
2 gene, as demonstrated by measurements of supernatant IL-2 activity . The only
exception was PHA alone, which resulted in detectable IL-2 activity in the
Stimulus Percent conver-
sion (range)
Induci-
bility
IL-2 production
(U/ml)
None* 0.13-0.23 - 0.0
Anti-Ti +PMA 0.62-2.0 + 6.4-20.4
Anti-Ti 0.16-0.40 - 0.0
PMA 0.18-0.35 - 0.0
Anti-HLA +PMA 0.23 - 0.0
Anti-HLA 0.26 - 0.0
PHA +PMA 3.38-7.07 + 23.8-77.0
PHA 0.21-0.37 - 5.2-8.8
A23187 + PMA 5.93-10.9 + 5 .5-29.3
A23187 0.22-0.25 - 0.0
Mock* 0.09-0.28 0.0DURAND ET AL .
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supernatant and no detectable CAT activity, possibly due to the sensitivity limits
of the transient transfection system. We conclude from the results in Table I
that the IL-2 5' flanking region is a target for the antigen receptor signal
pathway .
Calcium Ionophore plus PMA Can Induce Expression of the IL-2 CAT Construct in
theJurkat Cell Line. To further dissect the IL-2 gene activation pathway distal
to T3/Ti complex binding, we examined the effect of intracellular calcium
changes on expression of the IL-2 CAT plasmid . Triggering of the T3/Ti
complex is accompanied by an increase of cytoplasmic free calcium (8, 9) .
Moreover, calcium ionophores such as A23187 are able to substitute for anti-Ti
antibody in endogenous IL-2 gene activation (2, 8) . Although the A23187-
induced calcium increase may not mimic T3/Ti activation in all respects, it is
thought that A23187 acts distal to Ti binding by antigen (2, 5, 8) . As shown in
Table 1, this distal signal provided by A23187 complements PMA in activating
IL-2 CAT expression . Again, A23187 alone is an ineffective stimulus, as is anti-
Ti antibody alone .
Since the PMA stock was dissolved in 95% ethanol (at 1 mg/ml), and the
A23187 stock was dissolved in DMSO (at 50 mg/ml), we performed control
experiments to show that the necessary signals for the activation of our plasmids
are not due to the solvents, either directly or indirectly . First, neither PHA plus
ethanol, A23187 plus ethanol, PMA plus DMSO, norC305 plus ethanol induced
expression of the IL-2 CAT plasmid . Second, when the reagents were added to
fresh flasks and the solvents were allowed to evaporate before transfer of the
transfected cells to these flasks, no difference in the PHA plus PMA, A23187
plus PMA, and C305 plus PMA signals was seen compared to addition of the
reagents directly to the medium (data not shown) .
The 275 by IL-2Fragment Enhances Expressionfrom Linked Heterologous Promoter
after Stimulation of TransfectedJurkat Cells with Anti-Ti plusPMA as well as Calcium
lonophore plus PMA . To be certain that the 275 by fragment from the IL-2
gene was receiving the same physiologic signals as the larger 618 by fragment in
IL-2 CAT, we carried out experiments parallel to those described in Table I
using, instead, the 275 by fragment linked to the Fib CAT promoter (IL-
￿
Fib
CAT) . These results are shown in Table II and parallel those presented in Table
I . As shown for IL-2 CAT, anti-Ti plus PMA, PHA plus PMA, and calcium
ionophore plus PMA were capable of inducing the expression of the IL-
￿
Fib
CAT plasmid . Anti-Ti, PMA, calcium ionophore, and anti-HLA used separately,
as well as anti-HLA plus PMA were not able to induce IL-
￿
Fib CAT expression
in Jurkat . The fibrinogen promoter alone (Fib CAT) was not induced by any of
the signal combinations capable of inducing IL-
￿
Fib CAT, demonstrating that
the induction of IL-2 Fib CAT was dependent upon the presence of the 275 by
IL-2 fragment . We conclude that the 275 by IL-2 fragment is a target for signals
from the T cell antigen receptor pathway .
Calcium lonophore plus PMA Induces Expression of the IL-2 CAT Plasmid in a
Jurkat Mutant Cell Line that Fails to Express the T3/Ti Complexes at the Cell
Surface . As a test of our conclusion that the IL-2 5' flanking region is a target
for signals emanating from the T cell antigen receptor, weexamined the function40 2 INTERLEUKIN 2 GENE TARGET FOR ANTIGEN RECEPTOR SIGNALS
TABLE 11
Response of the Transfected IL-2 FIB CAT Plasmid in theJurkat T
Cell Line to Membrane and/or Cytosolic Signals
Stimulus
IL-2 Fib CAT
Percent conver-
￿
Induci-
￿
IL-2 production
sion (range)
￿
bility
￿
(U/ml)
None
￿
0.18-0.32 - 0.0-0.0
Anti-Ti +PMA
￿
0.40-0.49
￿
+
￿
11 .5-14.5
Anti-Ti
￿
0.20 - 0.0
Jurkat cells were transfected with the IL-2 Fib CAT plasmid and were
subsequently treated with the stimuli noted in the far left column . CAT
protein was extracted and CAT assays were performed as described in
Materialsand Methods . TheCAT assay results, given as percent conver-
sion, are representative of at least three separate experiments, except
where single values are given . These values were normalized to a mean
CATassay time of 18.2 haccording to the assumption that theCAT assay
is linear with respect to time (18and our unpublished observations) . CAT
assay times varied in these experiments from 16.2 to 22.3 h . Thepercent
-i
conversion values for 1L-2 Fib CATrepresented in the no stimulus range
are 0.18, 0.20, 0.20, 0.23, 0.28, 0.32, and 0.32, whereas the values for
the anti-Ti + PMA range are 0.40, 0.42, 0.44, and 0.49 . Inducibility is
defined by the criterion ofnonoverlapping ranges between stimulated and
unstimulated samples . IL-2 production is given in the far right column in
units per milliliter . We obtained the same 0.0 U/ml value for the IL-2 Fib
CATtransfection with A23187 +PMAstimulation upon repetition of the
bioassay. Note, however, that A23187 +PMA induced 5.5-8.4 U/ml in
the IL-2 CAT transfections ofJurkat (Table 1) and 44.4 U/ml in the IL-
2 CAT transfection of the Jurkat mutant (Fig. 2) . None and mock (under
the stimulus column) are as defined in Table I .
of the IL-2 CAT plasmid in a Jurkat mutant cell line (J . EMS-T3.3) that does
not express cell surface T3/Ti complexes (2, 3) . As illustrated in Fig . 2, only
A23187 plus PMA induces IL-2 CAT expression in this mutant cell line, while
neither PHA plus PMA nor C305 plus PMA can activate the IL-2 CAT plasmid
(compare the A23187 plus PMA lane in Fig. 2 with the PHA plus PMA and
PMA
Anti-HLA +PMA
Anti-HLA
PHA +PMA
A23187 +PMA
A23187
0.20-0.23
0.20
0.23
0.69-4.87
1.00
0.25
-
-
-
+
+
-
0.0
0.0
0.0
38.5-42.6
0.0
0.0
Mock 0.09-0.28
Fib CAT
None 0.27-0.34 - 0.0-0.0
Anti-Ti +PMA 0.21-0.39 - 10.0-12.3
Anti-Ti 0.29 - 0.0
PMA 0.29 - 0.0
Anti-HLA + PMA ND - ND
Anti-HLA ND - ND
PHA +PMA 0.17-0.36 - ND
A23187 +PMA 0.29 - ND
A23187 0.30 - ND
Mock 0.09-0.28DURAND ET AL .
￿
403
FIGURE 2 .
￿
Calcium ionophore plus PMA, but neither PHA plus PMA nor antibody to the
antigen receptor plus PMA activate the transfected IL-2 CAT plasmid in the Jurkat T3/Ti-
mutant .AJurkat mutant cell line lacking T3/Ti cell surface expression was transfected with
the IL-2 CAT plasmid . The cells were then stimulated with various signal combinations, and
the CAT extraction and assay were performed as described in Materials and Methods . A
photograph ofan x-ray film exposed to the thin-layer chromatography plate for 48 h is shown .
IL-2 production was assayed in the corresponding supernatants and is expressed in units per
milliliter at the bottom of each lane .
C305 plus PMA lanes) . In the Jurkat mutant, the expression of IL-2 CAT
paralleled the expression of the endogenous gene as indicated by the IL-2 activity
measurements on the bottom line of Fig . 2.
Discussion
We have identified aDNA sequence in the 5' flanking region of the IL-2 gene
with several of the operational characteristics of an inducible transcriptional
enhancer . This sequence, in either orientation, enhances the expression of a
linked gene . Furthermore, this sequence functions when linked to a heterologous
promoter and confers inducibility upon apromoter that is notnormally inducible .
The -326 to -52 (Xmn I to Ssp I) fragment from the IL-2 5' flanking region
represents the smallest sequence examined that can enhance expression from a
heterologous promoter in theJurkat cell line .
Beyond its definition as an enhancing sequence, we have shown that this 275
by IL-2 fragment is likely to be a target for signal transduction molecules in T
lymphocytes. We have demonstrated that a monoclonal antibody against the ,0
chain of theJurkatT cell antigen receptor is capable of activating expression of
a linked heterologous promoter through this 275 by fragment in the presence
of PMA . This result implies that the IL-2 5' flanking region contains target
sequences for a signal pathway originating at the T cell antigen receptor . That
A23187 plus PMA can activate the expression of IL-2 CAT in theJurkat mutant
lacking T3/Ti surface expression, whereas neither C305 plus PMA nor PHA404 INTERLEUKIN 2 GENE TARGET FOR ANTIGEN RECEPTOR SIGNALS
TABLE III
Sequence Homologies within the IL-2 5' Flanking Region
A.
B.
* Relative to the transcriptional start site.
plus PMA can, indicates that the activation ofthe IL-2 5' flanking region by the
anti-Ti antibody as well as by PHA is dependent upon the presence of T3/Ti
complexes; further, T3/Ti binding can be bypassed in theJurkat mutant by the
intracellular calcium increase provided by calcium ionophore in the activation of
the IL-2 5' flanking sequence (see Fig. 2).
The presence of an inducible nuclease-hypersensitive site within this 275 by
IL-2 fragment supports the notion that this region may be the target for signal
transduction molecules (see Fig. I and Siebenlist et al. [16]). Such nuclease-
sensitive areas arebelieved to representsites ofspecific DNA/protein interactions
(27, 28). Still other sequences may be central to the regulation ofthe IL-2 gene
aswell as otherTcell activation genes, whichmay be under coordinate regulatory
control (7). These genes may share certain regulatory sequences and their
correspondingsignal molecules. Notably, a (33/45 bp)homology (-297 to -252)
to the IFN-y promoter (-33 to -77) (29, 30), as well as a (9/11 bp) homology
(-87 to -97) to the IL-2 receptor promoter (-80 to -70) (31) lie within this
275 by IL-2 fragment. The latter homology is of interest because there is a
similar sequence in a similar location in the IFN-'1' gene, as shown in Table III
A.
We further examined the 275 by IL-2 fragment for internal homologies and
compared the sequence to other inducible enhancer elements. A 15/18 by
homology is repeated twice within the 275 by IL-2 fragment (Table III B). This
sequence bears homology to the cfos control element from -281 to -287 (on
the minus strand) in the cfos gene (32).
The cfos gene is particularly interesting in relation to IL-2 gene regulation,
because it falls into a class ofgenes that can be induced within 1 h after serum
stimulation of NIH 3T3 cells (32) or PHA stimulation of human peripheral
blood lymphocytes (15); both these inductions are likely to be, at least in part,
dependent upon membrane protein-binding events. The functional role of the
cfos element remains to be shown, though its homology to viral core enhancer
sequences has been noted (32). An understanding of the significance of these
homologies awaits the discovery of both the relevant signal molecules and their
specific target sequences, which will further define the mechanism by which
membrane and cytosolic triggering events lead to the activation ofT cell-specific
genes.
Our results lead directly to the next logical step in the investigation of IL-2
Gene segment Position* Sequence
Degree
of ho-
mology
IFN-y -66 to -54 TGTGAAAATACGT 11/13
IL-2 -97 to -85 TTTGAAAATATGT
IL-2 receptor -80 to -70 TTTGAAAAATT 9/11
IL-2 homology region I -291 to -274 AGAAAGGAGGAAAAACTG
IL-2 homology region II -142 to -122 AGAR GAGGAAAAA TG 15/18
cfos gene control element -281 to -287 GTGGAAA 6/7DURAND ET AL.
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gene regulation, namely, the isolation of the DNA binding molecule(s) that
activate(s) the IL-2 gene after antigenic stimulation. Several assays have recently
been developed that allow the detection and purification of DNA-binding pro-
teins.Theseassays are most readily applied andinterpretedonce asmall fragment
of DNA with clear functional importance has been isolated, criteria met by the
275 by fragment of IL-2 5' flanking sequence we have characterized.
Summary
Using a transient transfection assay, we have defined the sequences required
for the activation ofthe IL-2 gene in response to signals from the Tcell antigen
receptor. To do so we have transfected the human Tcell lineJurkat with hybrid
DNA constructs inwhich fragments from the IL-2 geneare linked to an indicator
gene . The indicator gene product, as well as IL-2 production from the endoge-
nous IL-2 gene were assayed after activation of the transfected Jurkat cells by
various stimuli. We have demonstrated that a 275 by fragment stretching from
52 to 326 by upstream of the IL-2 gene transcription initiation site is required
for expression ofthe linked indicator gene. This IL-2 gene fragment has several
of the characteristics of a transcriptional enhancer element, in that it functions
in both orientations and will enhance the expression from the promoter of an
unrelated gene. Such enhancement occurred only after activation ofJurkat cells
through the T cell antigen receptor. More specifically, this 275 by fragment
activated the expression ofa linked gene after binding ofa monoclonal antibody
to the Jurkat T cell antigen receptor in the presence of PMA. In addition,
calcium ionophore, which circumvents antigen receptor binding in T cell acti-
vation, induced the expression ofthe linked gene through this 275 by sequence,
in the presence of PMA. Finally, in a mutant Jurkat cell line lacking T3/antigen
receptor complexes at the cell surface, no expression due to the IL-2 5' flanking
region was seen after exposure to antibody to the T cell antigen receptor plus
PMA or to PHA plus PMA. In contrast, calcium ionophoreplus PMA did induce
the expression of a linked gene through the IL-2 5' flanking region in the
mutant Jurkat cell line. The responsiveness of the transfected hybrid genes
containing the IL-2 regulatory region paralleled the expression of the endoge-
nous IL-2 gene, as determined by IL-2 bioassays. We conclude that the 275 by
IL-2 sequence (-326 to -52 bp) is a target for the signal pathway originating at
the T cell antigen receptor. Definition of this 275 by target sequence should
now permit the isolation ofthe molecules thatbind to andactivate the IL-2 gene.
We thank Robert Shields for excellent technical assistance, Kathy Shaw for excellent
editorial assistance, and Kendall Smith for a thoughtful review ofthe manuscript.
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